| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1997;64:1764-1769
© 1997 The Society of Thoracic Surgeons
Departments of Surgery, and Medicine, and School of Public Health, Columbia University, College of Physicians & Surgeons, and The Presbyterian Hospital, New York, New York
Accepted for publication June 28, 1997.
Background. With the increasing use of left ventricular assist devices (LVADs) for longer-term support of patients awaiting cardiac transplantation, we must now consider whether to use these devices as alternatives to medical therapy when biologic hearts are needed but not forthcoming. This expansion of use depends as much on quality of life as it does on survival. To draw an inference about long-term quality of life with implanted LVADs, we studied "bridged" patients at our institution.
Methods. We elicited, by standard gamble, the utilities (preferences) of bridged patients at three points in their care: before LVAD implantation, during LVAD support, and after cardiac transplantation.
Results. Utility was 0.548 (±0.276) before implantation, 0.809 (±0.136) during LVAD support, and 0.964 (±0.089) after transplantation. For patients interviewed during all three states of health, the utilities were significantly different (p = 0.0009 by analysis of variance).
Conclusions. The quality of life with an LVAD was substantially better than with medical therapy, on par with renal transplantation (as established by others), and not as good as after cardiac transplantation. These results portend an acceptable quality of life for long-term use of LVADs for patients with end-stage heart failure and contribute to the growing body of evidence supporting a clinical trial to test this new use.
This article has been cited by other articles:
|
|
 |
|
  A. Messori, S. Trippoli, M. Bonacchi, and G. Sani Left ventricular assist device as destination therapy: application of the payment-by-results approach for the device reimbursement. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 480 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. D. Patel, E. S. Weiss, J. Schaffer, S. L. Ullrich, D. C. Rivard, A. S. Shah, S. D. Russell, and J. V. Conte Right Heart Dysfunction After Left Ventricular Assist Device Implantation: A Comparison of the Pulsatile HeartMate I and Axial-Flow HeartMate II Devices Ann. Thorac. Surg., September 1, 2008; 86(3): 832 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Sartipy, A. Albage, and D. Lindblom Improved Health-Related Quality of Life and Functional Status After Surgical Ventricular Restoration Ann. Thorac. Surg., April 1, 2007; 83(4): 1381 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Clegg, D. A. Scott, E. Loveman, J. L. Colquitt, P. Royle, and J. Bryant Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation Eur. Heart J., December 2, 2006; 27(24): 2929 - 2938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Petrucci, K. C. Truesdell, A. Carter, N. E. Goldstein, M. M. Russell, D. Dilkes, J. M. Fitzpatrick, C. E. Thomas, M. E. Keenan, L. A. Lazarus, et al. Cognitive dysfunction in advanced heart failure and prospective cardiac assist device patients. Ann. Thorac. Surg., May 1, 2006; 81(5): 1738 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. W. Stevenson and E. Lewis Mapping the Journey J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1612 - 1614. [Full Text] [PDF]
|
|
|
|
|
|
N. H. Thoennissen, M. Schneider, A. Allroggen, M. Ritter, R. Dittrich, C. Schmid, H. H. Scheld, E. B. Ringelstein, and D. G. Nabavi High level of cerebral microembolization in patients supported with the DeBakey left ventricular assist device J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1159 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Park, A. Tector, W. Piccioni, E. Raines, A. Gelijns, A. Moskowitz, E. Rose, W. Holman, S. Furukawa, O. H. Frazier, et al. Left ventricular assist devices as destination therapy: A new look at survival J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 9 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Nabavi, J. Stockmann, C. Schmid, M. Schneider, D. Hammel, H. H. Scheld, and E. B. Ringelstein Doppler microembolic load predicts risk of thromboembolic complications in Novacor patients J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 160 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Grady, P. Meyer, A. Mattea, D. Dressler, S. Ormaza, C. White-Williams, S. Chillcott, A. Kaan, B. Todd, A. Loo, et al. Predictors of Quality of Life at 1 Month After Implantation of a Left Ventricular Assist Device Am. J. Crit. Care., July 1, 2002; 11(4): 345 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Louis, I. R. Manousos, A. P. Coletta, A. L. Clark, and J. G.F. Cleland Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH Eur J Heart Fail, January 1, 2002; 4(1): 111 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Moskowitz, E. A. Rose, and A. C. Gelijns The cost of long-term LVAD implantation Ann. Thorac. Surg., March 1, 2001; 71 (2007): S195 - S198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Stevenson and R. L. Kormos Mechanical cardiac support 2000: current applications and future trial design: June 15-16, 2000 Bethesda, Maryland J. Am. Coll. Cardiol., January 1, 2001; 37(1): 340 - 370. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gagnon, M. Petty, and J. R Lahpor HeartMate(R) family of left ventricular assist systems Perfusion, July 1, 2000; 15(4): 345 - 354. [PDF]
|
|
|
|
|
|
P. Mohacsi, M. C. Deng, R. Murphy, C.-H. Bergh, E. Gronda, M. Komajda, R. Pacher, J. Spinar, K. Swedberg, and J. F. Cleland Implantable left ventricular assist systems (LVAS): Recent results. A report from a series of meetings sponsored by the Study Group on Advanced Heart Failure of the Working Group on Heart Failure Eur J Heart Fail, March 1, 2000; 2(1): 13 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L.S. Morales, K. A. Catanese, D. N. Helman, M. R. Williams, A. Weinberg, D. J. Goldstein, E. A. Rose, and M. C. Oz SIX-YEAR EXPERIENCE OF CARING FOR FORTY-FOUR PATIENTS WITH A LEFT VENTRICULAR ASSIST DEVICE AT HOME: SAFE, ECONOMICAL, NECESSARY J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 251 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Rose, A. J. Moskowitz, M. Packer, J. A. Sollano, D. L. Williams, A. R. Tierney, D. F. Heitjan, P. Meier, D. D. Ascheim, R. G. Levitan, et al. The REMATCH trial: rationale, design, and end points Ann. Thorac. Surg., March 1, 1999; 67(3): 723 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. W. Stevenson Inotropic Therapy for Heart Failure N. Engl. J. Med., December 17, 1998; 339(25): 1848 - 1850. [Full Text]
|
|
|
|
|
|
E. A. Rose, A. C. Gelijns, A. J. Moskowitz, D. F. Heitjan, L. W. Stevenson, W. Dembitsky, J. W. Long, D. D. Ascheim, A. R. Tierney, R. G. Levitan, et al. Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure N. Engl. J. Med., November 15, 2001; 345(20): 1435 - 1443. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
